The Spectrum of α-Thalassemia Mutations in Syrian Patients

Hemoglobin. 2023 Nov;47(6):245-248. doi: 10.1080/03630269.2023.2296927. Epub 2024 Jan 22.

Abstract

α-Thalassemia (α-thal) is a globally prevalent genetic disorder of hemoglobin (Hb) structure where the rate of α-globin chain synthesis is reduced or absent due to the presence of α-globin mutation(s). The aim of this study is to define the spectrum of α-globin gene mutations and evaluate their allele frequency in a group of α-thal carriers. A total of 55 individuals with possible α-thal patients were referred from the thalassemia centers in Syria. They have unexplained hypochromia and microcytosis. All patients were genetically tested for 21 common α-globin gene mutations using reverse hybridization kit. Seven different α-globin gene mutations and 13 different genotypes were detected in 55 patients. The two most frequently encountered mutations were -α3.7 deletion (47.1%) and --MED mutation (21.4%). The most commonly observed genotype was -α3.7/αα (40%), followed by --MED/αα genotype (21.8%). We determined the most common α thalassemia mutations in the Syrian patients. α-Thalassemia mutations with deletions were mostly observed in our study.

Keywords: Syria; α-Thalassemia -α3.7; α-globin genotype.

MeSH terms

  • Genotype
  • Hemoglobins / genetics
  • Humans
  • Mutation
  • Syria / epidemiology
  • alpha-Globins / genetics
  • alpha-Thalassemia* / genetics

Substances

  • Hemoglobins
  • alpha-Globins